04:06 AM EDT, 03/16/2026 (MT Newswires) -- Julie Rubinstein, President and Chief Operating Officer, on March 11, 2026, sold 179,703 shares in Adaptive Biotechnologies ( ADPT ) for $2,374,058. Following the Form 4 filing with the SEC, Rubinstein has control over a total of 507,934 common shares of the company, with 507,934 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1478320/000178066426000008/xslF345X05/form4.xml